Breathalyzer for diagnosis of lung diseases, potential for earlier detection

Breathalyzer for diagnosis of lung diseases
Some illnesses produce a unique molecular signature in a patient’s breath. Researchers are confident that quadrupole mass spectroscopy will make rapid diagnoses possible.

Siemens is researching a method that may make it possible to diagnose tuberculosis or lung cancer at an early stage using breath samples. The process involves an analysis of the molecular structure of the subject's breath. If the person concerned is ill, there is a shift in the relative quantities of molecules contained in his or her breath. As reported in the current issue of Pictures of the Future magazine, preliminary tests using breath samples from cancer and tuberculosis patients have been very promising. Now the process has to be verified using a larger and more diverse group of people.

According to the , 8.7 million people contracted tuberculosis worldwide in 2011 alone, and the disease killed 1.4 million patients that year. If this disease - which often seems to just be a bad cold when it starts - isn't diagnosed early enough, other people are infected. One effective solution involves a method that could help doctors recognize tuberculosis easily and early on. A method for reliably identifying lung cancer at an early stage has also been lacking until now. That's why the for a patient diagnosed with lung cancer is currently only around two years.

Scientists working for the Siemens department Corporate Technology are making use of the old insight that particular illnesses can be recognized by changes in the odors contained in a person's breath. The cocktail of highly complex molecules contained in a person's breath changes in specific ways when he or she is ill. Researchers use a quadrupole mass spectrometer to identify individual molecules and determine their concentration in the patient's breath. Here, the substances in the breath sample are electrically charged and accelerated through an which affects their trajectory. Particles of different weights are deflected to different degrees and thus land at different places on the detectors. In this way a kind of fingerprint is created from which conclusions about diseases can be drawn.

Now that trials with tuberculosis and patients have been successful, testing has to be carried out in order to determine what influences age, sex and diet have on measurements. Tests of smokers are also pending. If the initial positive results are confirmed, the technology could be further developed for practical applications. To make it suitable for use in a doctor's office, the spectrometer will have to be made small enough to fit inside a suitcase. Additionally, the software will need to be optimized so that it is simple to use.

add to favorites email to friend print save as pdf

Related Stories

Trial seeks to sniff out lung cancer

Jun 19, 2012

Cancer smells different. Past research has shown that dogs can detect lung cancer in a person’s breath with great accuracy. But dogs are  tricky to use as a diagnostic tool; what does it mean when a dog barks once ...

Cancer on the breath? The nose knows

May 16, 2011

A breath test for "sniffing out" cancer in a person's breath is a step closer to reality, according to a study recently published in the British Journal of Cancer. The study results show that the device develo ...

Please Exhale: Quick and Easy Breath Analysis

Nov 10, 2006

When we drink alcohol, its “flag” precedes us, and enjoyment of large amounts of garlic or onion can often be detected by others the next morning. However, our breath does not only betray what we have consumed; some diseases ...

Recommended for you

Dendritic cells affect onset and progress of psoriasis

Sep 12, 2014

Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine. The scientists suggest that new strate ...

Approach to deadly sepsis infections continues to vary

Sep 12, 2014

Treatment practices for patients hospitalised with the potentially fatal infection known as "sepsis" will continue to vary because of individual differences between hospitals and countries, according to University of Adelaide ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Tom_Hennessy
1 / 5 (2) Nov 30, 2012
The problem of vaccination was because they would use the same needle for everyone who got a vaccination. One can imagine what will happen with this mouthpiece being used to test for tuberculosis ? Will it EVER be sterilised or will it be used for everyone who is tested without ever being cleaned ?